NEA Management Company, LLC - CLOVIS ONCOLOGY INC ownership

CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 199 filers reported holding CLOVIS ONCOLOGY INC in Q3 2015. The put-call ratio across all filers is 0.94 and the average weighting 1.0%.

Quarter-by-quarter ownership
NEA Management Company, LLC ownership history of CLOVIS ONCOLOGY INC
ValueSharesWeighting
Q4 2016$50,634,000
+23.2%
1,139,8900.0%2.01%
+9.2%
Q3 2016$41,093,000
+162.8%
1,139,8900.0%1.84%
+127.1%
Q2 2016$15,639,000
-28.5%
1,139,8900.0%0.81%
-44.1%
Q1 2016$21,886,000
-45.1%
1,139,8900.0%1.45%
-42.8%
Q4 2015$39,896,000
-61.9%
1,139,8900.0%2.54%
-63.2%
Q3 2015$104,824,000
+4.6%
1,139,8900.0%6.91%
+32.0%
Q2 2015$100,174,000
-40.8%
1,139,890
-50.0%
5.23%
-31.6%
Q1 2015$169,228,000
+32.6%
2,279,7810.0%7.65%
+23.6%
Q4 2014$127,668,000
+23.5%
2,279,7810.0%6.19%
+17.8%
Q3 2014$103,411,000
+9.5%
2,279,7810.0%5.26%
+18.7%
Q2 2014$94,406,000
-40.2%
2,279,7810.0%4.43%
-42.9%
Q1 2014$157,920,000
+14.9%
2,279,7810.0%7.75%
+16.8%
Q4 2013$137,402,000
-0.9%
2,279,7810.0%6.64%
+20.9%
Q3 2013$138,611,000
-9.2%
2,279,7810.0%5.49%
-19.5%
Q2 2013$152,700,0002,279,7816.82%
Other shareholders
CLOVIS ONCOLOGY INC shareholders Q3 2015
NameSharesValueWeighting ↓
Versant Venture Management, LLC 814,833$60,485,054,00053.20%
Palo Alto Investors LP 2,121,857$157,505,0007.79%
NEA Management Company, LLC 2,279,781$169,228,0007.65%
EcoR1 Capital, LLC 243,048$18,041,0006.01%
Redmile Group, LLC 900,879$66,872,0006.00%
Opaleye Management Inc. 140,000$10,392,0004.82%
PFM Health Sciences, LP 2,266,756$168,261,0004.64%
Partner Investment Management, L.P. 40,798$3,028,0004.56%
CLIFTON PARK CAPITAL MANAGEMENT, LLC 826,919$61,383,0003.74%
Opus Point Partners Management, LLC 55,988$4,156,0003.48%
View complete list of CLOVIS ONCOLOGY INC shareholders